Phosphagenics - News Releases

News Releases

News Releases

Phosphagenics' latest News Releases can be accessed below.

(To view the latest regulatory filings and announcements click here)

2008

21 July 2008 - Phosphagenics July Newsletter

8 July 2008 - Phosphagenics appoints US based non-executive director

23 May 2008 - Annual General Meeting Results

23 May 2008 - Annual General Meeting - Chairman's and CEO address

20 May 2008 - Phosphagenics' executive appointment

07 May 2008 - Phosphagenics completes A$9.1m Capital Raising

30 April 2008 - Phosphagenics reports positive pre-clinical results for targeted delivery of lidocaine

21 April 2008 - Excellence in Biotechnology Investment Conference presentation

19 March 2008 - Phosphagenics initiates its Phase 2 clinical trial in type 1 diabetes

18 March 2008 - GRAS status opens door to U.S. food industry

27 February 2008 - Phosphagenics 2007 Financial Report/Appendix 4E

19 February 2008 - Phosphagenics initiates US clinical trials for its topical retinoic acid

11 February 2008 - Progression of Phosphagenics and NESTLÉ Nutrition's Phospha E trial

30 January 2008 - Phosphagenics reports superior pre-clinical cholesterol results from APA-01 and atorvastatin combination

2007

17 December 2007 - Successful transdermal oxycodone clinical trial results

04 December 2007 - Phosphagenics' presentation: BBY 2007 Healthcare & Life Sciences Conference

03 December 2007 - December 2007 Newsletter and Annual Report Retention Notice

19 October 2007 - Dietary supplement update

04 October 2007 - NESTLÉ Nutrition and Phosphagenics to commence Phospha E® Phase 2 clincial trial

24 September 2007 - Phase 1 transdermal oxycodone clinical trial approved

17 September 2007 - Phosphagenics to conduct a Phase 1 transdermal oxycodone clinical trial

12 September 2007 - Phosphagenics to commence Phase 2 TPM/Insulin clinical trial

30 August 2007 - Half Yearly Report and Accounts for the period ended 30 June 2007

08 August 2007 - Positive Phase 1b transdermal insulin clincial trial results

10 July 2007 - Phosphagenics lists on the International OTCQX market in the US

09 July 2007 - Phosphagenics and NESTLÉ extend option agreement

04 July 2007 - Phosphagenics information to be available through S&P Corporate Records Listing Program

21 June 2007 - Phosphagenics dermal delivery breakthrough

04 June 2007 - Phosphagenics awarded a $2.1 million AusIndustry Grant

25 May 2007 - Annual General Meeting - Chairman's Address

22 May 2007 - Phase 1b insulin clinical trial commenced

03 May 2007 - AusIndustry offers Phosphagenics a Pharmaceuticals Partnerships Program (P3) grant of $3.2 million

01 May 2007 - Phosphagenics to commence insulin clinical trial in May

24 April 2007 - 2006 Annual Report & AGM Documentation

15 March 2007 - Phosphagenics' presentation: Cowen and Company 27th Annual Health Care Conference

14 March 2007 - Phosphagenics to present at Cowen and Company 27th Annual Health Care Conference

07 March 2007 - Phosphagenics extends transdermal technology platform

23 February 2007 - Phosphagenics 2006 Financial Yearly Report/Appendix 4E

18 January 2007 - NESTLÉ Phospha E option agreement details

12 January 2007 - NESTLÉ enters commerical discussions with Phosphagenics

2006

14 December 2006 - Phospha E® pre-clinical studies with NESTLÉ Nutrition completed

12 December 2006 - Share placement of up to $A10m and $A5m share purchase plan

12 October 2006 - Completion of transdermal insulin clinical trial

11 October 2006 - Phosphagenics assigns license for Phospha E

10 October 2006 - Favourable toxicology results support broadening transdermal morphine clinical program

25 September 2006 - Phosphagenics' anti-cancer agent reduces tumour growth

30 August 2006 - 2006 Half Yearly Results

29 August 2006 - Phosphagenics signs agreement with major cosmetic company

24 August 2006 - Phosphagenics successfully delivers insulin across human skin

24 July 2006 - Phosphagenics commences Phase 1 trandermal insulin trial

03 July 2006 - Ethics approval for Phase I transdermal insulin clinical trial

26 May 2006 - Annual General Meeting presentations

25 May 2006 - Positive preclinical trial results for transdermal insulin

23 May 2006 - Phosphagenics plans to expand manufacturing capabilities

08 May 2006 - Phosphagenics initiates Phase 2a trial of it transdermal morphine

28 April 2006 - Phosphagenics & NESTLÉ Nutrition sign agreement for Phospha E®

21 April 2006 - 2005 Annual Report & AGM Documentation

27 March 2006 - Phosphagenics establishes American Depository Receipt Program

16 March 2006 - Phosphagenics 2005 Financial Yearly Report

24 January 2006 - Phosphagenics initiates trials with anti-cancer compound GTP-0805

18 January 2006 - Successful results from Phase 1b morphine clinical trial

Web Site Design & Business Hosting by Simple I.D.